BioSpace News Archive

Motorika’s cutting-edge robotic rehabilitation solutions to be installed in ORIGIN Polska’s state-of-the-art rehab centers in Poland

According to a report published by Grand View Research, the global legal cannabis market is expected to reach USD 146.4 Billion by end of 2025.

America’s #1 most trusted condom brand introduces Trojan Man™ as the ultimate guide to this big sexy world™

Mustang Bio, Inc. and St. Jude Children’s Research Hospital announced today that they have partnered and entered into an exclusive worldwide license agreement for the development of a firstin-class ex vivo lentiviral gene therapy for the treatment of X-linked severe combined immunodeficiency

Orsini Healthcare Specialty Pharmacy announced that it has been selected by Alnylam Pharmaceuticals, Inc to distribute ONPATTRO™ (patisiran) lipid complex injection.

Sorrento Therapeutics, Inc. announced that the first enrolled patient in the phase 1b study of its non-opioid, afferent nerve ablating drug candidate (resiniferatoxin or “RTX”) for the treatment of pain from osteoarthritis in the knee (intra-articular route of administration) received treatment on July 31, 2018.

The Canadian Medical Association (CMA) will release new findings on a growing healthcare generation gap driven by Canadians aged 18-34. The report will make the case for the need to accelerate technology and innovation in healthcare, from a policy and implementation perspective.

WellCare Health Plans, Inc. (NYSE: WCG) announced today that on August 10, 2018 it closed an offering of 5,207,547 shares of its common stock at a public offering price of $265.00 per share

Reflective of Growth of Small and Mid-Size Businesses Selecting Level-Funded and Self-Funded Plans in 2018 and 2019

Linda Mignone has joined Ultimate Medical Academy as Chief Marketing Officer.